Vireo Growth Inc. 8-K Filing
Ticker: VREOF · Form: 8-K · Filed: Dec 10, 2025 · CIK: 1771706
| Field | Detail |
|---|---|
| Company | Vireo Growth Inc. (VREOF) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $111 million |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Vireo Growth Inc. (ticker: VREOF) to the SEC on Dec 10, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $111 million (f the Company, credit bid approximately $111 million principal amount of Senior Secured Note).
How long is this filing?
Vireo Growth Inc.'s 8-K filing is 2 pages with approximately 696 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 696 words · 3 min read · ~2 pages · Grade level 14.4 · Accepted 2025-12-10 07:00:36
Key Financial Figures
- $111 million — f the Company, credit bid approximately $111 million principal amount of Senior Secured Note
Filing Documents
- tm2533123d1_8k.htm (8-K) — 24KB
- 0001104659-25-119847.txt ( ) — 181KB
- gdnsf-20251113.xsd (EX-101.SCH) — 3KB
- gdnsf-20251113_lab.xml (EX-101.LAB) — 33KB
- gdnsf-20251113_pre.xml (EX-101.PRE) — 22KB
- tm2533123d1_8k_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events In connection with the acquisition of a majority of the outstanding principal amount of 13% Senior Secured Convertible Notes due December 7, 2026 (the " Senior Secured Notes ") of Medicine Man Technologies, Inc. d/b/a Schwazze (" Schwazze "), Vireo Health of Colorado, LLC, a Colorado limited liability company and wholly-owned subsidiary of Vireo Growth Inc. (the " Company "), entered into a restructuring support agreement (the " RSA ") with Schwazze and certain related entities on October 10, 2025. The RSA sets forth a plan to restructure the operations and capital structure of Schwazze and its subsidiaries through a series of transactions, including, but not limited to (i) the purchase of certain assets representing a majority of the total assets of Schwazze and its subsidiaries (the " Asset Sale ") by a newly-formed entity (" NewCo ") to ultimately be majority owned by the Company, and (ii) the liquidation of Schwazze's remaining assets and winding down of Schwazze's remaining operations. The RSA provided for the Asset Sale to be effected by way of public disposition of collateral pursuant to 9-610 and 9-611 of the Uniform Commercial Code. On November 13, 2025, the Asset Sale took place and the collateral agent under the indenture governing the Senior Secured Notes, acting at the direction of the Company, credit bid approximately $111 million principal amount of Senior Secured Notes (the " Credit Bid "). The Company's Credit Bid was the winning bid at the Asset Sale. Following its win of the Credit Bid, Schwazze entered into an asset purchase agreement with NewCo on November 13, 2025, pursuant to which, subject to receipt of regulatory approvals and other closing conditions, the assets subject to the Asset Sale will be transferred to NewCo in consideration for an assumption by NewCo of certain specified liabilities of Schwazze and a discharge of the Senior Secured Notes included in the Credit Bid. At the closing of the Asset Sale, the e
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VIREO GROWTH INC. (Registrant) Date: December 10, 2025 By: /s/ Tyson Macdonald Tyson Macdonald Chief Financial Officer